Introduction {#section4-2050312119869110}
============

Global HIV prevalence among men who have sex with men (MSM) ranges from 3% in the Middle East and Southeast North Africa to 25% in the Caribbean countries.^[@bibr1-2050312119869110],[@bibr2-2050312119869110]^ HIV incidence has increased in many global settings since declines were noted in the United States and western Europe in the mid-1980s, despite that behavioral (e.g. risk reduction with condom use) and biomedical (e.g. pre-exposure prophylaxis (PrEP)) prevention tools are available.^[@bibr3-2050312119869110][@bibr4-2050312119869110]--[@bibr5-2050312119869110]^ Given the urgency of the global HIV epidemic in MSM, the available tools for preventing HIV acquisition among MSM may be too limited.^[@bibr3-2050312119869110],[@bibr5-2050312119869110]^ Voluntary male medical circumcision (VMMC) is a single surgical procedure providing potential lifelong benefit.^[@bibr3-2050312119869110]^ Both observational studies and clinical trials demonstrate that foreskin removal via VMMC reduces a man's risk of contracting HIV through condomless heterosexual intercourses by 50%--73%.^[@bibr6-2050312119869110][@bibr7-2050312119869110][@bibr8-2050312119869110]--[@bibr9-2050312119869110]^ The global public health community would be thrilled to have an "HIV vaccine" with efficacy at this level.

Many scholars have examined the efficacy of VMMC for preventing HIV transmission among MSM, but the conclusions have been inconsistent.^[@bibr10-2050312119869110],[@bibr11-2050312119869110]^ By the time of our data extraction, a few research teams conducted systematic review and meta-analyses of available observational evidence and their findings were both inconclusive.^[@bibr10-2050312119869110],[@bibr11-2050312119869110]^ Millet et al.^[@bibr10-2050312119869110]^ included 15 studies revealing insufficient evidence that VMMC protected against HIV infection among MSM.^[@bibr10-2050312119869110]^ By including six more studies, Wiysonge et al.^[@bibr11-2050312119869110]^ found the same overall conclusion, but data suggested that VMMC significantly protected MSM from HIV infection in the subgroup of men who primarily practiced insertive sex.^[@bibr11-2050312119869110]^ Furthermore, a recent meta-analysis revealed that the odds ratio (OR) of HIV infection between circumcised and uncircumcised MSM was 0.77 (95% confidence interval (CI), 0.67--0.89) without distinguishing the effect of VMMC by different sexual positions as well as other key individual and contextual factors that may play key roles in the studied association.^[@bibr12-2050312119869110]^

However, systematic reviews must incorporate social and contextual factors into their analyses, particularly the region of study and sexual position preferences. Compared to Western countries, the HIV epidemic in Asia differs in its later epidemic growth, comparatively low prevalence, and in the extreme social stigma faced by MSM.^[@bibr13-2050312119869110]^ As suggested by global literature, MSM in Africa may share similar behavioral patterns and social stigmas to their Asian peers,^[@bibr1-2050312119869110],[@bibr14-2050312119869110]^ region-specific strata can be compared to ensure that the comparatively vast literature on VMMC in MSM from the Americas and Europe does not draw out the comparatively small literature in Asia and Africa. Assessing the efficacy of VMMC among MSM by different characteristics of individuals and settings may also be revealing, for example, sex positioning, study sample size, measurement of exposure and outcome variables, and type of study design. By exploring different subgroups, we sought to better understand the efficacy of VMMC on HIV under different circumstances in the current analysis.

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (<http://www.prisma-statement.org/>), we sought to compare the odds of HIV infection between circumcised and uncircumcised MSM by including all available studies with appropriate study designs (e.g. randomized controlled trials (RCTs), well-designed quasi-experiments, and observational studies).

Methods {#section5-2050312119869110}
=======

Protocol and registration {#section6-2050312119869110}
-------------------------

We sought to register our meta-analysis with the PROSPERO, Cochrane, and Campbell systematic review databases, but were declined as we had "progressed beyond the point of completing data extraction at the time of registration." Nonetheless, we followed the PRISMA guidelines.

Eligibility criteria {#section7-2050312119869110}
--------------------

### Inclusion {#section8-2050312119869110}

Studies were included if they: (a) used an appropriate study design (e.g. RCTs, longitudinal studies, and observational studies), (b) were quantitatively evaluating effects of circumcision on HIV risk among MSM, (c) provided sufficient information to calculate effect size estimates, and (d) published (any language or year) either in peer-reviewed journals or in recognized conferences.

### Exclusion criteria {#section9-2050312119869110}

The exclusion criteria are as follows: (a) descriptive studies that do not report outcomes or studies that only report qualitative outcomes, (b) studies that do not focus on MSM (e.g. focus on heterosexual men), (c) reviews, and (d) theoretical articles without original data.

Data sources, search strategy, and study selection {#section10-2050312119869110}
--------------------------------------------------

Following the PRISMA guidelines, we conducted a comprehensive literature search through multiple databases by entering different combinations of a few MeSH terms up to 4 August 2016 ([Supplemental Table 1](https://journals.sagepub.com/doi/suppl/10.1177/2050312119869110)). We also searched through newspapers and conference proceedings, as well as references from article that met our inclusion criteria. The initial screening yielded 92 potentially relevant articles/abstracts from 117 entries identified in the search or through other sources ([Figure 1](#fig1-2050312119869110){ref-type="fig"}). These 92 abstracts were reviewed, 53 abstracts were excluded, and 39 were retained for further review. Two reviewers (C.Z. and Y.L.) independently reviewed the full texts of these articles. Disagreement between reviewers was resolved by discussion, and 33 articles fulfilled the inclusion criteria and were included in the analysis. In addition, four abstracts were selected based upon this review of references and all four were deemed eligible and their corresponding papers were included in the analysis.^[@bibr15-2050312119869110][@bibr16-2050312119869110][@bibr17-2050312119869110]--[@bibr18-2050312119869110]^ Hence, 37 articles from 33 studies were included for the systematic review and meta-analysis.

![Selection procedure of included studies in the meta-analysis.](10.1177_2050312119869110-fig1){#fig1-2050312119869110}

Data extraction {#section11-2050312119869110}
---------------

Two reviewers (C.Z. and Y.L.) independently extracted data from qualified articles using a standard form and developed a table containing the following information: (a) study location and time of conducting the study, (b) characteristics of participants (e.g. age and ethnicity), (c) sample size, (d) HIV assessment (e.g. either self-report or laboratory work), (e) circumcision assessment (either self-report or genital examination), (f) sex positions if applicable (e.g. receptive vs insertive), (g) number of HIV infections among circumcised and uncircumcised MSM, and (h) reported crude and/or adjusted odds ratios (aORs) of the HIV infection and VMMC. When information regarding any of the aforementioned information was unclear, we contacted the original authors of the included articles for further detailed information,^[@bibr19-2050312119869110]^ but no response had been received. For studies with duplicate publications,^[@bibr20-2050312119869110][@bibr21-2050312119869110][@bibr22-2050312119869110][@bibr23-2050312119869110][@bibr24-2050312119869110][@bibr25-2050312119869110]--[@bibr26-2050312119869110]^ we reported the study only once in the analyses, with the most complete data included.

Quality assessment {#section12-2050312119869110}
------------------

Two reviewers (C.Z. and Y.L.) independently assessed the risk of bias for each study. For our systematic review and meta-analysis, the selection bias may be unavoidable since we only considered articles with full texts among widely accessible online resources. In addition, we assessed the rigor of measuring the exposure (self-report vs genital examination) and outcome variables (self-report vs laboratory testing) in the original studies.

Statistical analysis {#section13-2050312119869110}
--------------------

### Measures of effects {#section14-2050312119869110}

Most studies reported strengths of association as OR with 95% CI. We preferred using aORs with 95% CIs from the given publication, available for 28 studies.^[@bibr14-2050312119869110],[@bibr16-2050312119869110][@bibr17-2050312119869110][@bibr18-2050312119869110][@bibr19-2050312119869110][@bibr20-2050312119869110][@bibr21-2050312119869110][@bibr22-2050312119869110][@bibr23-2050312119869110][@bibr24-2050312119869110][@bibr25-2050312119869110][@bibr26-2050312119869110][@bibr27-2050312119869110][@bibr28-2050312119869110][@bibr29-2050312119869110][@bibr30-2050312119869110][@bibr31-2050312119869110][@bibr32-2050312119869110][@bibr33-2050312119869110][@bibr34-2050312119869110][@bibr35-2050312119869110][@bibr36-2050312119869110][@bibr37-2050312119869110][@bibr38-2050312119869110][@bibr39-2050312119869110][@bibr40-2050312119869110][@bibr41-2050312119869110][@bibr42-2050312119869110][@bibr43-2050312119869110][@bibr44-2050312119869110]--[@bibr45-2050312119869110]^ For five studies that did not report aORs, we used raw data to calculate the crude ORs and their 95% CIs.^[@bibr15-2050312119869110],[@bibr46-2050312119869110][@bibr47-2050312119869110][@bibr48-2050312119869110]--[@bibr49-2050312119869110]^

### Assessment of heterogeneity {#section15-2050312119869110}

To evaluate the extent to which studies' outcomes were consistent, we employed the *I*^2^*-*statistics and corresponding 95% CIs to depict heterogeneity. The *I*^2^*-*statistics describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error, and it varies from 0% to 100% with higher percentages indicating higher heterogeneity.^[@bibr50-2050312119869110]^ If the 95% CIs included 0, the included studies were considered to be reasonably homogeneous. *P*-values for *I*^2^*-*statistics were also reported.

### Assessment of publication bias {#section16-2050312119869110}

Publication bias was assessed by the funnel plots, based on the assumption that in the absence of significant heterogeneity, study effect sizes will be normally distributed around the mean effects.^[@bibr50-2050312119869110]^ A funnel plot is a scatterplot of study effects (i.e. *x*-axis) against a measure of study precision (i.e. *y*-axis). As a tool visually assesses publication bias, funnel plots would produce asymmetry if publication bias exists.

### Data synthesis {#section17-2050312119869110}

*Model selection*: we employed the random-effects model, as all included studies were conducted among different populations and different settings, a feature that may influence the effects observed. The random-effects model was designed to capture the variance of effects across studies.^[@bibr50-2050312119869110],[@bibr51-2050312119869110]^ Each study was assigned a weight directly by the calculating procedure. Forest plot of ORs from the included studies (i.e. the area of each square is proportional to study's weight in the meta-analysis), with the summary measure (center line of diamond) and associated CIs (lateral tips of diamond), and a solid vertical line of no effect was used. STATA V12 (College Station, TX, USA), the command *metan*, was used for data syntheses and analyses.

*Subgroup analyses* were performed to examine the effect size by sex positioning (receptive vs insertive), study design (cross-sectional vs studies with follow-ups), geographical region (Asia vs non-Asia; Asia + Africa vs non-Asia/non-Africa), assessment method (self-report vs genital exam), and sample size at baseline (⩽3000 vs \>3000). All stratified variables were derived from empirical literature^[@bibr1-2050312119869110],[@bibr14-2050312119869110],[@bibr13-2050312119869110]^ as well as discussion among the research team.

*Sensitivity analyses* were employed to examine the stability of the efficacy of circumcision by evaluating whether the overall effect size was sensitive to exclusion of any individual studies (e.g. study with highest or lowest weight and with smallest or largest sample size).

*Heterogeneity* was assessed by the *I*^2^-statistics and its corresponding *P*-value that describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error, with higher percentages indicating higher heterogeneity (e.g. 30%--60% indicating moderate heterogeneity and 75%--100% indicating considerable heterogeneity) were presented to depict heterogeneity.^[@bibr50-2050312119869110]^

Results {#section18-2050312119869110}
=======

Overall effect size {#section19-2050312119869110}
-------------------

A total of 117,293 MSM participants from 33 studies contributed to examining the association between circumcision and HIV risk. Among these studies, four studies revealed that circumcision significantly reduced the odds of HIV infection among MSM,^[@bibr15-2050312119869110],[@bibr28-2050312119869110],[@bibr39-2050312119869110],[@bibr49-2050312119869110]^ while 29 studies reported that circumcision had no statistically significant associations with HIV. The overall effect size of circumcision on HIV infection was statistically significant (aOR, 0.93; 95% CI, 0.88--0.99; [Figure 2](#fig2-2050312119869110){ref-type="fig"}). In addition, details about each included study are presented in [supplemental Table 2](https://journals.sagepub.com/doi/suppl/10.1177/2050312119869110).

![Overall effect size for 33 included studies of voluntary medical male circumcision and HIV risk among men who have sex with men (*N* = 33).](10.1177_2050312119869110-fig2){#fig2-2050312119869110}

Subgroup analyses {#section20-2050312119869110}
-----------------

### By sex positioning {#section21-2050312119869110}

Among included studies, 11 studies^[@bibr14-2050312119869110],[@bibr16-2050312119869110],[@bibr23-2050312119869110][@bibr24-2050312119869110]--[@bibr25-2050312119869110],[@bibr30-2050312119869110],[@bibr31-2050312119869110],[@bibr37-2050312119869110],[@bibr40-2050312119869110],[@bibr43-2050312119869110],[@bibr47-2050312119869110]^ have reported circumcision data for insertive anal sex, and six studies^[@bibr14-2050312119869110],[@bibr23-2050312119869110],[@bibr24-2050312119869110],[@bibr37-2050312119869110],[@bibr43-2050312119869110],[@bibr47-2050312119869110],[@bibr48-2050312119869110]^ reported data on receptive anal sex among MSM. We performed stratified analysis by sex positioning. The results revealed that the odds of HIV risk among circumcised MSM who primarily/exclusively practiced insertive sex did not suggest protection (aOR, 1.16; 95% CI, 0.73--1.83), nor did the odds among circumcised MSM practicing receptive anal sex (aOR, 0.97; 95% CI, 0.74--1.28). However, the insertive sex group estimate was distorted substantially by a single study (i.e. an outlier study with the aOR of HIV infection of 1.77 comparing circumcised to uncircumcised MSM among the insertive sex group, which is in the opposite direction from all other studies in this subgroup), the findings of which were highly disparate from other comparable studies.^[@bibr47-2050312119869110]^ When this one outlier study that suggested greater risk for circumcised men who primarily/exclusively practiced insertive sex was excluded, the odds of HIV infection among circumcised MSM who primarily/exclusively practiced insertive sex (aOR, 0.51; 95% CI, 0.23--1.11) suggested a protective effect for circumcision among the insertive MSM ([Table 1](#table1-2050312119869110){ref-type="table"}).

###### 

Subgroup analyses of included studies.

![](10.1177_2050312119869110-table1)

                                                                                                                               Number of studies   Number of participants   aOR (95% CI)        *I*^2^ (%)   *P*-value for heterogeneity chi-square
  ---------------------------------------------------------------------------------------------------------------------------- ------------------- ------------------------ ------------------- ------------ ----------------------------------------
  Overall                                                                                                                      33                  117,293                  0.93 (0.88, 0.99)   54           \<0.0001
  By sex positioning                                                                                                                                                                                         
   Insertive                                                                                                                   11                  15,946                   1.16 (0.73, 1.83)   14.6         0.31
   Insertive (after deleting Zeng et al.^[@bibr47-2050312119869110]^)^[a](#table-fn2-2050312119869110){ref-type="table-fn"}^   10                                           0.51 (0.23, 1.11)   0.00         0.89
   Receptive                                                                                                                   6                   9244                     0.97 (0.74, 1.28)   28.0         0.23
  By study regions                                                                                                                                                                                           
   Asia                                                                                                                        8                   17,458                   0.69 (0.58, 0.81)   39.3         0.12
   Non-Asia                                                                                                                    25                  99,835                   0.97 (0.91, 1.03)   45.0         0.007
   Asia + Africa                                                                                                               9                   17,821                   0.62 (0.53, 0.73)   70.1         0.001
   Non-Asia/non-Africa                                                                                                         24                  99,472                   0.99 (0.93, 1.05)   0.00         0.86
  By sample size                                                                                                                                                                                             
   Smaller size (\<3000)                                                                                                       24                  22,510                   0.70 (0.61, 0.82)   39.3         0.024
   Larger size (⩾3000)                                                                                                         9                   94,783                   0.98 (0.92, 1.04)   52.3         0.033
  By study design                                                                                                                                                                                            
   Cross-sectional                                                                                                             24                  92,937                   0.92 (0.87, 0.98)   61.9         \<0.0001
   Cohort                                                                                                                      9                   24,356                   1.01 (0.86, 1.19)   0.0          0.47
  By sampling strategy                                                                                                                                                                                       
   Convenience sampling                                                                                                        17                  54,235                   0.95 (0.88, 1.03)   41.6         0.037
   Non-convenience sampling                                                                                                    16                  63,058                   0.92 (0.85, 0.99)   63.6         0.000
   Non-probability-based                                                                                                       28                  100,448                  0.95 (0.68, 1.34)   0.0          0.67
   Probability-based                                                                                                           5                   16,845                   0.93 (0.88, 0.99)   59.6         \<0.0001
  By HIV testing                                                                                                                                                                                             
   Lab test                                                                                                                    27                  99,896                   0.93 (0.88, 0.99)   59.4         \<0.0001
   Self-report                                                                                                                 6                   17,397                   0.95 (0.75, 1.20)   4.0          0.39
  By VMMC                                                                                                                                                                                                    
   Genital examination                                                                                                         9                   32,715                   0.98 (0.90, 1.07)   0.0          0.61
   Self-report                                                                                                                 24                  84,578                   0.90 (0.84, 0.97)   62.1         \<0.0001
  By exposure and outcome measurement                                                                                                                                                                        
   Using genital examination and laboratory testing                                                                            9                   32,715                   0.98 (0.90, 1.07)   0.0          0.61
   One measured                                                                                                                18                  67,181                   0.93 (0.88, 0.99)   59.4         \<0.0001
   Neither measured                                                                                                            6                   17,397                   0.95 (0.75, 1.20)   4.0          0.39

aOR: adjusted odds ratio; CI: confidence interval; VMMC: voluntary medical male circumcision.

The study (Zeng et al.^[@bibr47-2050312119869110]^) is an outlier. After deleting, the odds of HIV risk among insertive MSM were lower compared to the odds of HIV risk among MSM who primarily practice receptive or versatile sex positioning.

### By study design {#section22-2050312119869110}

Among all 33 studies, 24 employed a cross-sectional study design. A protective and significant association was noted among these studies (aOR, 0.92; 95% CI, 0.87--0.98). Nine studies with a cohort design^[@bibr20-2050312119869110],[@bibr22-2050312119869110],[@bibr23-2050312119869110],[@bibr25-2050312119869110],[@bibr34-2050312119869110],[@bibr36-2050312119869110],[@bibr37-2050312119869110],[@bibr49-2050312119869110],[@bibr52-2050312119869110]^ revealed a non-significant association (aOR, 1.01; 95% CI, 0.86--1.19; [Table 1](#table1-2050312119869110){ref-type="table"}).

### By region {#section23-2050312119869110}

\(a\) Asia versus non-Asia: eight studies^[@bibr14-2050312119869110],[@bibr15-2050312119869110],[@bibr17-2050312119869110],[@bibr18-2050312119869110],[@bibr27-2050312119869110],[@bibr28-2050312119869110],[@bibr47-2050312119869110],[@bibr49-2050312119869110]^ were conducted in Asian countries. Among non-Asian MSM, there was no protection of circumcision against HIV infection (aOR, 0.97; 95% CI, 0.91--1.03). (b) Among studies conducted in Asian countries, the odds of being HIV infected was 31% lower compared with the odds of HIV infection among uncircumcised (aOR, 0.69; 95% CI; 0.58--0.81). (c) Only one African study was found. Examining Asian/African studies combined meant adding the African study to the five Chinese and three Indian, revealing an even lower odd of being HIV infected among circumcised MSM than Asian MSM alone (aOR, 0.62; 95% CI; 0.53--0.73). Similarly, the odds of HIV infection among circumcised MSM outside the Asian-African continents was still non-significant (aOR, 0.99; 95% CI, 0.93--1.05; [Table 1](#table1-2050312119869110){ref-type="table"}).

### By sample size {#section24-2050312119869110}

For studies with ⩽3000 participants (*n* = 24), we found that the odds of being HIV infected among circumcised MSM was significantly lower (aOR, 0.70; 95% CI, 0.61--0.82). For studies with a sample size of \>3000 (*n* = 9),^[@bibr15-2050312119869110],[@bibr19-2050312119869110],[@bibr32-2050312119869110],[@bibr34-2050312119869110],[@bibr36-2050312119869110],[@bibr37-2050312119869110],[@bibr41-2050312119869110],[@bibr42-2050312119869110],[@bibr52-2050312119869110]^ the OR of HIV infection was close to 1 (aOR, 0.99; 95% CI, 0.93--1.05; [Table 1](#table1-2050312119869110){ref-type="table"}).

### By sampling strategy {#section25-2050312119869110}

Of the 17 studies using a convenience sampling strategy, the odds of being HIV infected among circumcised MSM was 5% less compared with uncircumcised MSM (aOR, 0.95; 95% CI; 0.88--1.03). For studies employing some kind of systematic sampling, the odds of being HIV infected was significantly lower among circumcised MSM (aOR, 0.92; 95% CI, 0.85--0.99). Only five studies employed probability sampling,^[@bibr20-2050312119869110],[@bibr21-2050312119869110],[@bibr22-2050312119869110],[@bibr31-2050312119869110],[@bibr34-2050312119869110],[@bibr36-2050312119869110]^ and the odds of being HIV infected was slightly lower among circumcised (aOR, 0.93; 95% CI, 0.88--0.99), similar to the studies that did not use probability sampling (aOR, 0.95; 95% CI; 0.68--1.34; [Table 1](#table1-2050312119869110){ref-type="table"}).

### By assessment method {#section26-2050312119869110}

For nine studies employing genital examinations to measure circumcision status and laboratory testing of HIV infection,^[@bibr14-2050312119869110],[@bibr18-2050312119869110],[@bibr20-2050312119869110],[@bibr23-2050312119869110],[@bibr24-2050312119869110],[@bibr31-2050312119869110],[@bibr37-2050312119869110],[@bibr41-2050312119869110],[@bibr44-2050312119869110],[@bibr47-2050312119869110]^ the odds of being HIV infected was similar between circumcised and uncircumcised MSM (aOR, 0.98; 95% CI, 0.90--1.07). For six studies employing self-report for both variables,^[@bibr16-2050312119869110],[@bibr30-2050312119869110],[@bibr33-2050312119869110],[@bibr35-2050312119869110],[@bibr42-2050312119869110],[@bibr43-2050312119869110]^ the odds of getting HIV was also only slightly lower among circumcised men (aOR, 0.95; 95% CI, 0.75--1.20). The rest of the 18 studies with either, but not both measures using a medical examination had a marginally significant HIV prevention benefit suggested for circumcision (aOR, 0.93; 95% CI, 0.88--0.99; [Table 1](#table1-2050312119869110){ref-type="table"}).

Sensitivity analyses {#section27-2050312119869110}
--------------------

Sensitivity analyses were conducted by removing studies with highest and lowest weight, and studies with largest and smallest sample size, respectively. By comparing outcomes from sensitivity analyses with the original outcome, no difference has been found from the sensitivity analyses (not shown). In the subgroup analysis for men with an insertive sexual preference, a wide swing in aOR was noted when one study was excluded.^[@bibr47-2050312119869110]^

Publication bias and heterogeneity assessment {#section28-2050312119869110}
---------------------------------------------

By examining the funnel plot, publication bias was present as the scatter plot shows asymmetry within the funnel, especially among studies with smaller ORs ([Figure 3](#fig3-2050312119869110){ref-type="fig"}). The *I*^2^-statistics was 54.0% (*P* \< 0.001), indicating moderate heterogeneity of included studies (i.e. the degree of the variation across studies due to heterogeneity rather than chance is moderate).^[@bibr50-2050312119869110]^

![Funnel plot for publication bias assessment for included studies for the meta-analysis of voluntary medical male circumcision and HIV infection.](10.1177_2050312119869110-fig3){#fig3-2050312119869110}

Discussion {#section29-2050312119869110}
==========

Our meta-analytic review includes 117,293 participants from 33 studies. Our review shows that the odds of being HIV infected are lower among MSM who are circumcised than among MSM who are uncircumcised, but the effect size is modest (7% protection, 95% CI, 1%--12%). Our meta-analysis is the first to report a statistically protective effect of VMMC against HIV infection among MSM. The evidence for the protective effect of VMMC is stronger among MSM who live in Asia or Africa. Our findings suggest that VMMC may be a protective tool against HIV infection among MSM, especially for those living in Asia and Africa.^[@bibr53-2050312119869110],[@bibr54-2050312119869110]^

In addition to the overall effect size, several key findings emerged from the subgroup analyses. First, the observation that VMMC may be an especially effective tool for HIV prevention among Asian and African MSM generates a hypothesis that circumcision may be more effective in MSM who have comparatively lower risk profiles (e.g. fewer sexual partners, less risky sexual activity) or MSM in context with stronger HIV epidemics in heterosexual transmission compared with their Western peers.^[@bibr3-2050312119869110],[@bibr14-2050312119869110],[@bibr49-2050312119869110]^ Therefore, VMMC could be more effective among MSM with moderate risk, but that MSM with higher risk profiles may benefit less. Future studies are desired to validate this hypothesis that VMMC works more effectively among low-risk profile MSM than their high-risk peers. Second, although our findings showed increased odds of HIV infection among circumcised MSM primarily practicing insertive sex, a counterintuitive and biologically implausible finding was noted. A strong protective effect of VMMC on HIV infection among MSM exclusively or predominantly practicing insertive anal intercourse was noted after we removed an outlier from the analytic pool. Third, for studies with a sample size of ⩽3000 MSM, the OR of being HIV infected was 30% significantly lower among circumcised MSM compared to their uncircumcised peers. Based upon the funnel plot assessment, perhaps studies with fewer participants can be published only if they reported significant findings, while studies with larger sample sizes are published without bias, that is, whether the association is significant or not. Therefore, publication bias may affect the accuracy and reliability of the efficacy of VMMC, a bias away from the null hypothesis.

Our meta-analysis has several strengths. First, it included a large number of participants. Second, we stratified the data by individual and contextual characteristics to capture any potential associations in important subgroups. Third, we strictly followed the PRISMA guideline for systematic reviews and meta-analyses.

However, a number of limitations should be considered while interpreting findings from this study. First, the limited number and scope of existing studies constrained representativeness of our findings. Of the 33 studies, 22 (67%) were conducted in high-income regions (e.g. United States and Canada) with long-standing lesbian/gay/bisexual/transgender (LGBT) civil rights movements and high HIV prevalence among MSM. This geographic concentration may not reflect the full scope of sexual risk and HIV transmission dynamics worldwide.^[@bibr53-2050312119869110],[@bibr54-2050312119869110]^ The limited number of studies (*n* = 13) from Asia (*n* = 8), Africa (*n* = 1), and Latin America (*n* = 4) limits our ability to generalize findings. Second, misclassification of circumcision status and sex positioning may lead to a bias toward the null hypothesis, minimizing the ability to detect the true magnitude of association. The limited assessment of circumcision status and sex positioning may lead to misclassification that would tend to under/overestimate VMMC benefits.^[@bibr11-2050312119869110],[@bibr14-2050312119869110]^ When misclassification bias is eliminated by conducting direct penile examination as well as by including detailed sexual position data, promise in VMMC as a tool to reduce HIV risk among MSM than previously assumed.^[@bibr14-2050312119869110]^ Third, the nature of cross-sectional study designs may limit the inference of the association between VMMC and HIV. In addition, our subgroup analysis among all cross-sectional studies revealed a protective association between VMMC and HIV risk, while the pooled OR among cohort studies was null. Perhaps, the significantly protective association was driven by uncontrolled/unadjusted confounding in these cross-sectional studies. Studies with more rigorous design are highly desired. Furthermore, no available information to assess potential risk compensation behaviors after circumcision among all included studies may require attention by future studies.^[@bibr55-2050312119869110],[@bibr56-2050312119869110]^

Conclusion {#section30-2050312119869110}
==========

Although the overall effect of VMMC on HIV prevention was marginally significant, misclassification of key exposure and confounding variables may dilute the protective effect of VMMC. In turn, publication bias may exaggerate its protective effort. Research with more rigorous study designs to objectively assess HIV infection through confirmatory serological tests and evaluation of circumcision by genital exam can significantly reduce misclassification bias. In addition, future research should collect detailed data on MSM's sexual position preference at different time points in their lives (e.g. in the past 30 days, in the past 6 months, and lifetime), as well as the degree of their sexual risk taking. We would not be surprised if we eventually learn that circumcision is highly protective for MSM, but benefits are predominantly accrued among men practicing predominantly insertive anal sex and men without highest risk behavior patterns.^[@bibr57-2050312119869110]^ Furthermore, two-thirds of the included studies in this meta-analysis employed convenience sampling to collect data, which may lack representativeness and constrain capacity of making casual inferences. Although an RCT could definitively determine whether VMMC reduces HIV risk among MSM, no available RCT has been conducted. An RCT, if feasible, should be conducted. An integration of behavioral and biomedical HIV prevention is highly desired.^[@bibr4-2050312119869110],[@bibr5-2050312119869110],[@bibr58-2050312119869110]^
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